Outcome: Sustained
JAN172019_01B5203
Our summary
Physician researcher in pathology and cellular biology sought EB-2 with national interest waiver for hematological malignancy research. AAO sustained appeal, finding all three Dhanasar prongs met: research has substantial merit and national importance, petitioner well-positioned by experience and publication record, and waiver benefits U.S. healthcare interests.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
What the AAO accepted
- Merit and national importance · Research on hematological malignancies and molecularly targeted therapies has substantial merit; significant prospective impact on cancer understanding and treatment.
- Well positioned · Physician's experience, published work, high citation rates, and record of successful research contributions position him well to advance proposed research.
- Balance favors a waiver · Petitioner's track record of successful research and significance of work to advance U.S. healthcare interests outweigh availability of other qualified workers.
What was missing
Every criterion in the table was found met.
Criteria
| Criterion | Reading | Why |
|---|---|---|
| Met | Research on hematological malignancies and molecularly targeted therapies has substantial merit; significant prospective impact on cancer understanding and treatment. | |
| Met | Physician's experience, published work, high citation rates, and record of successful research contributions position him well to advance proposed research. | |
| Met | Petitioner's track record of successful research and significance of work to advance U.S. healthcare interests outweigh availability of other qualified workers. |
A published decision describes one case. It is not legal advice and not a prediction for yours.
